Therapy of chronic lymphocytic leukemia (CLL) - from past to present
Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in Western European countries. This disease occurs mainly in adult population at an age of over 50 years, more commonly in men. Many years of research have shown that CLL is a disease with a very diverse clinical course and varia...
Saved in:
Main Authors: | Anna Gumieniczek (Author), Bogumiła Ciseł (Author), Katarzyna Lipska (Author), Agata A. Filip (Author) |
---|---|
Format: | Book |
Published: |
Polish Pharmaceutical Society,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival
by: Nancy Nisticò, et al.
Published: (2020) -
Genomic characterization of chronic lymphocytic leukemia (CLL) in radiation-exposed Chornobyl cleanup workers
by: Juhi Ojha, et al.
Published: (2018) -
Synthesis and Biochemical Evaluation of Ethanoanthracenes and Related Compounds: Antiproliferative and Pro-Apoptotic Effects in Chronic Lymphocytic Leukemia (CLL)
by: James P. McKeown, et al.
Published: (2024) -
Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) with Reed-Sternberg-like cells with no convincing evidence of classic Hodgkin lymphoma
by: Latha K Abraham, et al.
Published: (2024) -
Common for COVID-19 cytokine storm in patients with SARS-CoV-2 infection and CLL (chronic lymphocytic leukemia)
by: Yozlem Kobakova, et al.
Published: (2024)